Analyst consensus rating
CONMED Analyst Rating: Hold
Direct answer
CONMED's consensus rating is Hold.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $46.83.
Forecast evidence checked November 12, 2026.
Get free CONMED email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $50.77
- Average price target
- $46.83
- High price target
- $50.00
- Low price target
- $43.00
- Low target gap
- -15.3%
- Target upside
- -7.8%
- High target gap
- -1.5%
- Target range width
- 13.8%
- Consensus rating
- Hold
- Analysts
- 6
- Evidence date
- November 12, 2026
- Valid through
- November 19, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for CONMED?
CONMED has a verified Hold consensus. The same dataset has an average price target of $46.83.
How far are CONMED's low and high targets from the recorded price?
The low target implies -15.3%, while the high target implies -1.5%.
How many analysts are included in CONMED's consensus?
The verified consensus includes 6 analysts.
How is CONMED's target upside or downside calculated?
The average target of $46.83 is divided by the recorded price of $50.77, then one is subtracted to produce -7.8%. This does not guarantee a future return.
When was CONMED's analyst forecast verified?
The data was verified on 2026-11-12. The dataset is valid through 2026-11-19.